Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q43087932)
Watch
English
Association of reduced relative dose intensity and survival in lymphoma patients receiving CHOP-21 chemotherapy.
scientific article published on 26 February 2008
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PMC publication ID
2275304
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18299833%20AND%20SRC:MED&resulttype=core&format=json
retrieved
3 January 2020
title
Association of reduced relative dose intensity and survival in lymphoma patients receiving CHOP-21 chemotherapy
(English)
1 reference
stated in
Europe PubMed Central
PMC publication ID
2275304
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18299833%20AND%20SRC:MED&resulttype=core&format=json
retrieved
3 January 2020
main subject
chemotherapy
1 reference
based on heuristic
inferred from title
author
Matthias Schwenkglenks
series ordinal
2
1 reference
stated in
Europe PubMed Central
PMC publication ID
2275304
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18299833%20AND%20SRC:MED&resulttype=core&format=json
retrieved
3 January 2020
author name string
R Pettengell
series ordinal
1
1 reference
stated in
Europe PubMed Central
PMC publication ID
2275304
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18299833%20AND%20SRC:MED&resulttype=core&format=json
retrieved
3 January 2020
A Bosly
series ordinal
3
1 reference
stated in
Europe PubMed Central
PMC publication ID
2275304
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18299833%20AND%20SRC:MED&resulttype=core&format=json
retrieved
3 January 2020
publication date
26 February 2008
1 reference
stated in
Europe PubMed Central
PMC publication ID
2275304
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18299833%20AND%20SRC:MED&resulttype=core&format=json
retrieved
3 January 2020
published in
Annals of Hematology
1 reference
stated in
Europe PubMed Central
PMC publication ID
2275304
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18299833%20AND%20SRC:MED&resulttype=core&format=json
retrieved
3 January 2020
volume
87
1 reference
stated in
Europe PubMed Central
PMC publication ID
2275304
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18299833%20AND%20SRC:MED&resulttype=core&format=json
retrieved
3 January 2020
issue
5
1 reference
stated in
Europe PubMed Central
PMC publication ID
2275304
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18299833%20AND%20SRC:MED&resulttype=core&format=json
retrieved
3 January 2020
page(s)
429-430
1 reference
stated in
Europe PubMed Central
PMC publication ID
2275304
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18299833%20AND%20SRC:MED&resulttype=core&format=json
retrieved
3 January 2020
cites work
Dose and outcome: the hurdle of neutropenia (Review).
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2275304
retrieved
25 May 2018
EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphomas and solid tumours
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2275304
retrieved
25 May 2018
Achievement of optimal average relative dose intensity and correlation with survival in diffuse large B-cell lymphoma patients treated with CHOP.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2275304
retrieved
15 August 2018
Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of elderly patients with aggressive lymphomas: results of the NHL-B2 trial of the DSHNHL.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2275304
retrieved
15 August 2018
Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of young patients with good-prognosis (normal LDH) aggressive lymphomas: results of the NHL-B1 trial of the DSHNHL.
1 reference
stated in
PubMed Central
reference URL
https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2275304
retrieved
15 August 2018
Identifiers
DOI
10.1007/S00277-008-0447-2
1 reference
stated in
Europe PubMed Central
PMC publication ID
2275304
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18299833%20AND%20SRC:MED&resulttype=core&format=json
retrieved
3 January 2020
PMC publication ID
2275304
1 reference
stated in
Europe PubMed Central
PMC publication ID
2275304
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18299833%20AND%20SRC:MED&resulttype=core&format=json
retrieved
3 January 2020
PubMed publication ID
18299833
1 reference
stated in
Europe PubMed Central
PMC publication ID
2275304
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18299833%20AND%20SRC:MED&resulttype=core&format=json
retrieved
3 January 2020
ResearchGate publication ID
5552182
0 references
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit